RBPJ mutations identified in two families affected by Adams-Oliver syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22883147.
- Also identified by DOI 10.1016/j.ajhg.2012.07.005 and PMC identifier 3415535.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Through exome resequencing, we identified two unique mutations in recombination signal binding protein for immunoglobulin kappa J (RBPJ) in two independent families affected by Adams-Oliver syndrome (AOS), a rare multiple-malformation disorder consisting primarily of aplasia cutis congenita of the vertex scalp and transverse terminal limb defects. These identified mutations link RBPJ, the primary transcriptional regulator for the Notch pathway, with AOS, a human genetic disorder. Functional assays confirmed impaired DNA binding of mutated RBPJ, placing it among other notch-pathway proteins altered in human genetic syndromes.
Medical subject headings
- Ectodermal Dysplasia
- Genetic Predisposition to Disease
- Immunoglobulin J Recombination Signal Sequence-Binding Protein
- Limb Deformities, Congenital
- Scalp Dermatoses